SIGA Technologies/$SIGA
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About SIGA Technologies
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
- Ticker
- $SIGA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 49
- Headquarters
- New York, United States
- Website
- www.siga.com
SIGA Metrics
BasicAdvanced
$229M
-
-$0.04
0.89
$0.60
18.81%
Price and volume
Market cap
$229M
Beta
0.89
52-week high
$8.55
52-week low
$2.83
Average daily volume
635K
Dividend rate
$0.60
Financial strength
Current ratio
21.717
Quick ratio
15.902
Total debt to equity
0.003
Profitability
EBITDA (TTM)
-10.547
Gross margin (TTM)
16.28%
Net profit margin (TTM)
-5.19%
Operating margin (TTM)
-20.76%
Effective tax rate (TTM)
49.44%
Revenue per employee (TTM)
$1,100,000
Management effectiveness
Return on assets (TTM)
-3.39%
Return on equity (TTM)
-1.49%
Valuation
Price to revenue (TTM)
4.26
Price to book
1.39
Price to tangible book (TTM)
1.39
Price to free cash flow (TTM)
-11.153
Free cash flow yield (TTM)
-8.97%
Free cash flow per share (TTM)
-0.286
Dividend yield (TTM)
18.81%
Growth
Revenue change (TTM)
-70.13%
Earnings per share change (TTM)
-103.41%
3-year revenue growth (CAGR)
-18.13%
10-year revenue growth (CAGR)
19.97%
3-year earnings per share growth (CAGR)
-53.76%
10-year earnings per share growth (CAGR)
-26.50%
What the Analysts think about SIGA
Analyst ratings (Buy, Hold, Sell) for SIGA Technologies stock.
Analyst projections of the future price of SIGA Technologies stock.
SIGA Financial Performance
Revenues and expenses
SIGA Earnings Performance
Company profitability
Upcoming events
No upcoming events
SIGA News
AllArticlesVideos
Funds containing SIGA
AllUSDGBPEUR
Fund name | Fund size | $SIGA weighting |
|---|---|---|
iShares Nasdaq US Biotechnology$BTEC | $1.2B | 0.01% |
iShares Nasdaq US Biotechnology£BTEK | £865M | 0.01% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.